Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
The association between GTF2H5 and trichothiodystrophy is supported by multiple independent case reports and multi‐patient studies. Patients consistently present with core features such as brittle, sulfur‑deficient hair, ichthyosis, and neuroectodermal abnormalities including global developmental delay and alopecia (PMID:20075106).
Genetic evidence is robust, with several unrelated probands identified harboring distinct deleterious variants in GTF2H5. For example, one report described a neonate harboring a pathogenic variant, c.29T>A (p.Ile10Lys) (PMID:30359777). Additional families, including sibling pairs reported in independent studies (PMID:30580289), further reinforce segregation of pathogenic alleles along with consistent phenotypic findings.
Trichothiodystrophy due to GTF2H5 variants follows an autosomal recessive inheritance pattern. Segregation analysis in these families has revealed multiple affected relatives carrying biallelic variants, supporting the independent co‐segregation of the disorder (PMID:30359777).
Functional and experimental assessment has demonstrated that pathogenic mutations in GTF2H5 lead to destabilization of the TFIIH complex. In vitro and in vivo studies show altered transcription and impaired nucleotide excision repair, which concordantly reproduce the cellular defects seen in patient cells (PMID:15220921, PMID:25620205).
In summary, the convergence of clinical, genetic, and functional data across diverse studies robustly supports a strong association between GTF2H5 and trichothiodystrophy. This integrated evidence is compelling for diagnostic decision‑making, commercial testing, and future research publications.
Key Take‑home: Disruption of GTF2H5 leads to TFIIH instability and a consequent defect in DNA repair and transcription, establishing its strong clinical utility as a diagnostic marker for trichothiodystrophy.
Gene–Disease AssociationStrongMultiple independent probands and families with segregating variants, supported by consistent clinical and functional data across studies (PMID:20075106, PMID:30359777). Genetic EvidenceStrongAt least two distinct pathogenic variants identified (e.g. c.29T>A (p.Ile10Lys)) in unrelated probands with familial segregation evidence, fulfilling ClinGen genetic criteria. Functional EvidenceModerateExperimental studies demonstrate that GTF2H5 mutations impair TFIIH complex stability, leading to defective transcription and nucleotide excision repair that mirror patient cellular phenotypes (PMID:15220921, PMID:25620205). |